Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Htg Molecular Dia (HTGM)

Htg Molecular Dia (HTGM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,160
  • Shares Outstanding, K 920
  • Annual Sales, $ 8,910 K
  • Annual Income, $ -17,150 K
  • 60-Month Beta 0.92
  • Price/Sales 0.52
  • Price/Cash Flow N/A
  • Price/Book 3.34
Trade HTGM with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 235.70%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -2.41
  • Number of Estimates 1
  • High Estimate -2.41
  • Low Estimate -2.41
  • Prior Year -8.28
  • Growth Rate Est. (year over year) +70.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.20 +52.19%
on 01/06/23
7.31 -33.38%
on 01/13/23
+0.88 (+22.06%)
since 12/30/22
3-Month
2.38 +104.25%
on 12/07/22
23.64 -79.40%
on 12/12/22
-1.27 (-20.73%)
since 11/02/22
52-Week
2.38 +104.25%
on 12/07/22
35.40 -86.24%
on 02/09/22
-28.13 (-85.24%)
since 02/02/22

Most Recent Stories

More News
Three Small-Cap Biotech Stocks to Consider Now

This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023 

HARP : 1.0600 (-3.64%)
HTGM : 4.90 (+8.41%)
ABEO : 2.82 (+6.42%)
HTG Molecular Diagnostics, Inc. (HTGM) Reports Q3 Loss, Misses Revenue Estimates

HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of 21.15% and 44.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

HTGM : 4.90 (+8.41%)
AFMD : 1.2650 (-1.17%)
Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 36.36% and 11.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

STIM : 6.38 (+3.24%)
HTGM : 4.90 (+8.41%)
ReWalk Robotics (RWLK) Reports Q3 Loss, Lags Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -50% and 51.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

RWLK : 0.8407 (+1.07%)
HTGM : 4.90 (+8.41%)
HTG Molecular Diagnostics, Inc. (HTGM) Moves to Buy: Rationale Behind the Upgrade

HTG Molecular Diagnostics, Inc. (HTGM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

HTGM : 4.90 (+8.41%)
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of -9.52% and 4.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TMCI : 24.25 (+3.19%)
HTGM : 4.90 (+8.41%)
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of 95% and 2.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

INGN : 25.59 (+6.05%)
HTGM : 4.90 (+8.41%)
HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11

TUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision...

HTGM : 4.90 (+8.41%)
HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition

TUCSON, Ariz., July 19, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision...

HTGM : 4.90 (+8.41%)
HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility

TUCSON, Ariz., July 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision...

HTGM : 4.90 (+8.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include...

See More

Key Turning Points

3rd Resistance Point 5.35
2nd Resistance Point 5.07
1st Resistance Point 4.79
Last Price 4.90
1st Support Level 4.23
2nd Support Level 3.95
3rd Support Level 3.67

See More

52-Week High 35.40
Fibonacci 61.8% 22.79
Fibonacci 50% 18.89
Fibonacci 38.2% 15.00
Last Price 4.90
52-Week Low 2.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar